Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia

Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia

US Patent 11427539 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Highly structured porous silica materials and biological uses thereof2025
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglyca2025
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglyca2025
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2025
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2025
Porous silica material for use as a pharmaceutical or dietary active ingredient2024
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemi2024
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemi2024
Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia2023
Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia2023
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2023
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglyc2023